214 related articles for article (PubMed ID: 33603343)
1. Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma.
Yang H; Jing H; Han X; Tan H; Cheng W
Drug Des Devel Ther; 2021; 15():531-542. PubMed ID: 33603343
[TBL] [Abstract][Full Text] [Related]
2. IR-820@NBs Combined with MG-132 Enhances the Anti-Hepatocellular Carcinoma Effect of Sonodynamic Therapy.
Wang X; Wang C; Tian H; Chen Y; Wu B; Cheng W
Int J Nanomedicine; 2023; 18():6199-6212. PubMed ID: 37933299
[TBL] [Abstract][Full Text] [Related]
3. Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma.
Tian H; Shang H; Chen Y; Wu B; Wang C; Wang X; Cheng W
Int J Nanomedicine; 2023; 18():7079-7092. PubMed ID: 38050474
[TBL] [Abstract][Full Text] [Related]
4. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
[TBL] [Abstract][Full Text] [Related]
6. PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.
Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Koch A; Evers BM
Anticancer Res; 2010 Dec; 30(12):4951-8. PubMed ID: 21187475
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-sufficient lipid nanobubbles combined with UTMD for enhanced sonodynamic therapy of Hep-G2 cells.
Tan H; Tian Y; Yang H; Liu Z; Liang X; Li B; Cheng W
J Biomed Mater Res B Appl Biomater; 2021 Nov; 109(11):1796-1806. PubMed ID: 33838006
[TBL] [Abstract][Full Text] [Related]
8. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma.
Kim MN; Lee SM; Kim JS; Hwang SG
Cancer Chemother Pharmacol; 2019 Oct; 84(4):809-817. PubMed ID: 31385002
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma.
Wu B; Yuan Y; Liu J; Shang H; Dong J; Liang X; Wang D; Chen Y; Wang C; Zhou Y; Jing H; Cheng W
J Nanobiotechnology; 2021 Jun; 19(1):177. PubMed ID: 34118951
[TBL] [Abstract][Full Text] [Related]
10. Tumor Targeting with Apatinib-loaded Nanoparticles and Sonodynamic Combined Therapy.
Han X; Zhou C; Luo X; Pang H; Han C; Tang L; Yang Z; Nong Y; Lu C
Curr Mol Med; 2024; 24(5):648-666. PubMed ID: 37312441
[TBL] [Abstract][Full Text] [Related]
11. Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy.
Zhang P; Ren Z; Chen Z; Zhu J; Liang J; Liao R; Wen J
Drug Des Devel Ther; 2018; 12():4207-4216. PubMed ID: 30573951
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
13. Redox cycling of copper by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated modulation of redox scavengers, DNA damage and cell death in diethylnitrosamine induced hepatocellular carcinoma.
Khan S; Zafar A; Naseem I
Bioorg Chem; 2020 Jun; 99():103818. PubMed ID: 32276135
[TBL] [Abstract][Full Text] [Related]
14. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic effect of chromanone derivative, hyrtiosone A from marine demosponge Hyrtios erectus in hepatocellular carcinoma HepG2 cells.
Chakraborty K; Francis P
Bioorg Chem; 2021 Sep; 114():105119. PubMed ID: 34252861
[TBL] [Abstract][Full Text] [Related]
16. Sinoporphyrin sodium based sonodynamic therapy induces anti-tumor effects in hepatocellular carcinoma and activates p53/caspase 3 axis.
Li E; Sun Y; Lv G; Li Y; Zhang Z; Hu Z; Cao W
Int J Biochem Cell Biol; 2019 Aug; 113():104-114. PubMed ID: 30660690
[TBL] [Abstract][Full Text] [Related]
17. RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC.
Chen Y; Shang H; Wang C; Zeng J; Zhang S; Wu B; Cheng W
Int J Nanomedicine; 2022; 17():105-123. PubMed ID: 35027829
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
19. Carnosic acid induces apoptosis of hepatocellular carcinoma cells via ROS-mediated mitochondrial pathway.
Zhang X; Chen Y; Cai G; Li X; Wang D
Chem Biol Interact; 2017 Nov; 277():91-100. PubMed ID: 28918123
[TBL] [Abstract][Full Text] [Related]
20. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]